Unraveling the genetic landscape of susceptibility to multiple primary cancers
Preprint
Abstract
With advances in cancer screening and treatment, there is a growing population of cancer survivors who may develop subsequent primary cancers. While hereditary cancer syndromes account for only a portion of multiple cancer cases, we sought to explore the role of common genetic variation in susceptibility to multiple primary tumors. We conducted a cross-ancestry genome-wide association study (GWAS) and transcriptome-wide association study (TWAS) of 10,983 individuals with multiple primary cancers, 84,475 individuals with single cancer, and 420,944 cancer-free controls from two large-scale studies. Our GWAS identified six lead variants across five genomic regions that were significantly associated (P-8 ) with the risk of developing multiple primary tumors (overall and invasive) relative to cancer-free controls (at 3q26, 8q24, 10q24, 11q13.3, and 17p13). We also found one variant significantly associated with multiple cancers when comparing to single cancer cases (at 22q13.1). Multi-tissue TWAS detected associations with genes involved in telomere maintenance in two of these regions ( ACTRT3 in 3q26 and SLK and STN1 in 10q24) and the development of multiple cancers. Additionally, the TWAS also identified several novel genes associated with multiple cancers, including two immune-related genes, IRF4 and TNFRSF6B . Telomere maintenance and immune dysregulation emerge as central, common pathways influencing susceptibility to multiple cancers. These findings underscore the importance of exploring shared mechanisms in carcinogenesis, offering insights for targeted prevention and intervention strategies.Keywords
All Related Versions
- Published version: Human Genetics and Genomics Advances, 6 (2), 100413.
This publication has 104 references indexed in Scilit:
- Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristicsCancer, 2021
- Non-canonical roles of canonical telomere binding proteins in cancersCellular and Molecular Life Sciences, 2021
- Fine‐mapping and QTL tissue‐sharing information improves the reliability of causal gene identificationGenetic Epidemiology, 2020
- Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinomaFrontiers of Medicine, 2020
- Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor PhenotypesThe American Journal of Human Genetics, 2018
- Association Between Telomere Length and Risk of Cancer and Non-Neoplastic DiseasesJAMA Oncology, 2017
- Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancerJournal of Cancer Research and Clinical Oncology, 2017
- Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere lengthInternational Journal of Cancer, 2014
- Cumulative effect of genome‐wide association study‐identified genetic variants for bladder cancerInternational Journal of Cancer, 2014
- Epidemiology of Multiple Primary Cancers2009